Status:
COMPLETED
Neuroinflammatory Response in Patients With ICH and IVH Treated With rtPA
Lead Sponsor:
University of Rijeka
Conditions:
Hypertensive Intracerebral Hemorrhage
Intraventricular Hemorrhage
Eligibility:
All Genders
18-80 years
Brief Summary
This study compares the neuroinflammatory response in patients with hypertensive ICH associated with IVH treated with intraventriculary applied rtPA, and the control group. The inflammatory mediator c...
Eligibility Criteria
Inclusion
- Subjects with primary ICH with IVH
- ICH score 2-4, , with origin of the hematoma in the basal ganglia and blood in the third and/or ventricle
- Patient is not considered a surgical candidate by neurosurgery service
Exclusion
- No history of diseases or drugs that affect the immunological system.
- ICH score 1 and 5
- Current participation in another research drug treatment protocol
- Previously known intracranial arteriovenous malformation or aneurysms
- Intracerebral hematoma considered to be related to trauma
- ICH is located in the pons
- Blood in the subarachnoid space visualized on CT scan
Key Trial Info
Start Date :
June 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2018
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT03452722
Start Date
June 1 2011
End Date
September 1 2018
Last Update
March 26 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.